CNS
-
Read FlipbookDelivering CNS Trials Requires Specialized Clinical Knowledge
-
1:00:15Watch VideoThrough the Drug Development Looking Glass: Rare Disorders and the Treatment of Pain
-
Read Flipbook
Post-Partum Depression Case Study: WCG Services for CNS Trials
-
Read Flipbook
Movement Disorder Case Study: WCG Services for CNS Trials
-
Read PostBlazing New Trails in Rare Disease & CNS Clinical Studies: An Interview with Dr. Mark Opler
-
Read PostOn the Future of Psychiatric Disorders: Part 1 of WCG’s Transforming CNS Trials Series
-
Read PostOn the Future of Schizophrenia Trials: Part 2 of WCG’s Transforming CNS Trials Series
-
Read PostOn the Future of Depression Trials: Part 3 of WCG's Transforming CNS Trials Series
-
Read PostOn the Future of Movement Disorder Trials: Part 4 of WCG’s Transforming CNS Trials Series
-
Read PostCNS Trial Failures Problematic But Fixable, Experts Agree
-
Read Flipbook
Improving Subject Selection and Endpoint Management in Alzheimer's Trials
-
Read FlipbookQuality First: Using Data to Inform Site Selection in CNS
WCG MedAvante-ProPhase espouses a rather simple philosophy: minimize variability, generate cleaner data.
-
Read FlipbookAddressing Suggestibility as a Psychological Phenomenon in Clinical Trials
It is important to understand patient perspectives and to anticipate how subjects in research studies may be impacted by the presence of digital tools, devices, and mobile health applications
-
1:50Watch Video90 Second Insights: eCOA modifications and implementation during COVID-19
-
Read FlipbookQ&A with CNS Expert, Dr. Andrew Cutler
Dr. Cutler, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conversation with Mark Opler, MD, PhD, chief research officer at WCG-MedAvante-ProPhase.
-
25:31Watch VideoInterview with Dr. Andrew Cutler
Dr. Cutler shares his insights on the current challenges and opportunities for CNS therapies and clinical trials during an energizing conversation with Dr. Mark Opler.
-
Read FlipbookQ&A with CNS Expert, Dr. Philip Scheltens
Philip Scheltens, MD, PhD, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conversation with Christopher Randolph, PhD, ABPP-CN, chief scientific officer...
-
Read FlipbookQ&A with CNS Expert, Dr. Leslie Citrome
Leslie Citrome, MD, MPH, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conversation with Mark Opler, MD, PhD, chief research officer at WCG-MedAvante-ProPhase.
-
Read FlipbookQ&A with CNS Expert, Dr. Michael Liebowitz
Dr. Michael Liebowitz, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conversation with...
-
Read FlipbookQ&A with CNS Expert, Dr. Christoph U. Correll
Christoph U. Correll, MD, a member of WCG’s Scientific Leadership Team, shared his thoughts in a recent conversation with Mark Opler, MD, PhD, chief research officer at WCG-MedAvante-ProPhase.
-
Loading More...
